Methylation of this gene’s promoter leads to a decreased synthesis of the MGMT enzyme and has been independently associated with increased survival in infiltrating gliomas, including GBMs, as a result of an increased response to temozolomide [36,37,38,39]. Here, MGMT is linked to central nervous system cancer.